Trial Profile
Therapeutic Effect of Irbesartan, AVAPRO, on Blood Pressure and eGFR by Morning or Bedtime Administration in Chronic Kidney Disease Patients(ABPM-CKD)
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms ABPM-CKD
- 09 Nov 2011 New trial record